Table 1 Characteristics of participants with DED and non-DED.

From: Prevalence of dry eye disease symptoms and impact on quality-of-life among hospital staff during the COVID-19 pandemic

Variables

Overall

(n = 1,250)

DED

(n = 776)

Non-DED

(n = 474)

p value

Age; year (mean age ± SD)

39.92 ± 11.04

39.38 ± 11.25

38.16 ± 10.67

0.057

Gender; n (%)

    

Female

987 (79.0)

654 (84.3)

333 (70.3)

 < 0.001*

Male

263 (21.0)

122 (15.7)

141 (29.7)

 

Occupation; n (%)

    

Administrative personnel

456 (36.5)

256 (33.0)

200 (42.2)

 < 0.001*

Nurse

344 (27.5)

247 (31.8)

97 (20.5)

 

Researcher or research personnel

292 (23.4)

171 (22.1)

121 (25.5)

 

Physician

85 (6.8)

53 (6.8)

32 (6.8)

 

Physician assistant/ nursing assistant

37 (3.0)

27 (3.5)

10 (2.1)

 

Pre-clinic instructor

11 (0.9)

9 (1.2)

2 (0.4)

 

Missing data

25 (2.0)

13 (1.7)

12 (2.5)

 

Underlying systemic diseases; n (%)

    

Atopic diseases

215 (17.2)

172 (22.2)

43 (9.1)

 < 0.001*

Dyslipidemia

153 (12.2)

112 (14.4)

41 (8.6)

0.002*

Hypertension

128 (10.2)

87 (11.2)

41 (8.6)

0.147

Diabetes mellitus

34 (2.7)

19 (2.4)

15 (3.2)

0.450

Neurological diseases

7 (0.6)

5 (0.6)

2 (0.4)

0.609

Underlying eye diseases; n (%)

    

Preexisting dry eye

255 (20.4)

230 (29.6)

25 (5.3)

 < 0.001*

Allergic conjunctivitis

52 (4.2)

47 (6.1)

5 (1.1)

 < 0.001*

Pinguecula or pterygium

42 (3.4)

34 (4.4)

8 (1.7)

0.010*

Refractive error and main types of correction; n (%)

805 (64.4)

578 (74.5)

227 (47.9)

 < 0.001*

No correction

93 (7.4)

70 (9.0)

23 (4.9)

 

Glasses

650 (52.0)

470 (60.6)

180 (38)

 

Contact lenses

155 (12.4)

115 (14.8)

40 (8.4)

 

Laser vision correction

33 (2.6)

25 (3.2)

8 (1.7)

 

Previous eyelid surgery; n (%)

58 (4.6)

40 (5.2)

18 (3.8)

0.272

Periocular botulinum toxin injection; n (%)

84 (6.7)

57 (7.3)

27 (5.7)

0.263

Device use time/day; hours (median, IQR)

    

Total

8 (5, 10)

8 (5, 10)

8 (5, 12)

0.002*

For work

6 (3, 8)

5 (2, 8)

6 (4, 8)

 < 0.001*

Most common type of device used; n (%)

    

Mobile phone

746 (59.7)

431 (55.5)

315 (66.5)

 < 0.001*

Computer/Tablet

490 (39.2)

339(43.7)

151 (31.8)

 

Television

14 (1.1)

6 (0.8)

8 (1.7)

 

Sleep time per night; hours (mean ± SD)

6.47 ± 1.03

6.40 ± 1.00

6.57 ± 1.07

0.007*

Mask wearing time per day; hours (mean ± SD)

9.41 ± 2.99

9.55 ± 3.00

9.19 ± 2.96

0.045*

Mask types; n (%)

    

Surgical mask/ fabric mask

939 (75.1)

565 (72.8)

374 (78.9)

0.106

N95 mask

76 (6.1)

53 (6.8)

23 (4.9)

 

Double masking (any types of masks)

235 (18.8)

158 (20.4)

77 (16.2)

 

Frequency of artificial tears use; n (%)

    

Every day

111 (8.9)

97 (12.5)

14 (2.9)

 < 0.001*

Occasional (not every day)

385 (30.8)

304 (39.2)

81(17.1)

 

Never

754 (60.3)

375 (48.3)

379 (80)

 
  1. *: p value < 0.05, DED: dry eye disease, IQR: interquartile range; non-DED: non-dry eye disease, SD: standard deviation.